Table 2 Frequencies of promoter methylation which significantly differ in between ovarian clear cell adenocarcinoma and benign endometriotic cysts
From: Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
| Â | Percentage (case number) | Â | |
|---|---|---|---|
Gene name | Clear cell | Benign ovarian cyst | p value |
| Â | n=47 | N=29 | Â |
RASS328 | 72% (34) | 0% (0) | <0.001 |
RASS382 | 77% (36) | 0% (0) | <0.001 |
APC | 15% (7) | 0% (0) | 0.029 |
CDKN2A | 2% (1) | 20% (6) | 0.006 |
CDH13 | 47% (22) | 0% (0) | <0.001 |
SCG148 | 40% (19) | 14% (4) | 0.014 |
SCG409 | 13% (6) | 0% (0) | 0.046 |
SFRP5211 | 23% (11) | 0% (0) | 0.004 |
CCND2220 | 30% (14) | 6% (2) | 0.001 |
CCND2142 | 51% (24) | 24% (7) | 0.02 |
CACNA1A | 43% (20) | 0% (0) | <0.001 |